INFINITY PHARMACEUTICALS INC (INFIQ)
Institutional ownership reported to the SEC as of Q4 2023, across 21 quarters.
3
Reporting holders
$15
Reported value
0.0%
Held as options
+1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Highlander Capital Management, LLC | $9 | 3,500 | 0.00% | new | NEW |
| Able Wealth Management LLC | $5 | 2,000 | 0.00% | new | FIRST |
| Livelsberger Financial Advisory | $1 | 200 | 0.00% | new | FIRST |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2023 | 3 | $15 | 5,700 | 1 | 0 | 0 | 0.0% |
| Q3 2023 | 2 | $2.9K | 181,168 | 1 | 0 | 0 | 0.0% |
| Q2 2023 | 42 | $4.2M | 19,691,958 | 3 | 4 | 13 | 0.7% |
| Q1 2023 | 45 | $3.0M | 18,780,610 | 2 | 9 | 9 | 0.9% |
| Q4 2022 | 55 | $12.1M | 21,548,232 | 10 | 6 | 15 | 1.1% |
| Q3 2022 | 73 | $37.4M | 30,896,101 | 14 | 9 | 26 | 1.6% |
| Q2 2022 | 70 | $19.3M | 30,019,931 | 15 | 12 | 25 | 1.5% |
| Q1 2022 | 90 | $44.9M | 38,959,481 | 8 | 15 | 36 | 1.3% |
| Q4 2021 | 97 | $99.4M | 42,019,121 | 8 | 29 | 30 | 4.9% |
| Q3 2021 | 105 | $167.3M | 46,923,914 | 24 | 29 | 27 | 4.0% |
| Q2 2021 | 96 | $134.3M | 43,787,086 | 33 | 20 | 25 | 2.5% |
| Q1 2021 | 82 | $140.1M | 42,133,494 | 39 | 25 | 8 | 2.5% |
| Q4 2020 | 54 | $69.9M | 32,560,282 | 19 | 9 | 11 | 1.2% |
| Q3 2020 | 42 | $32.2M | 27,437,791 | 4 | 7 | 7 | 0.3% |
| Q2 2020 | 44 | $25.1M | 27,793,384 | 3 | 11 | 8 | 0.0% |
| Q1 2020 | 48 | $23.4M | 27,930,995 | 7 | 6 | 11 | 0.0% |
| Q4 2019 | 46 | $27.6M | 28,704,931 | 3 | 8 | 11 | 0.1% |
| Q3 2019 | 50 | $30.3M | 29,339,134 | 3 | 4 | 13 | 0.1% |
| Q2 2019 | 56 | $55.4M | 30,697,348 | 6 | 8 | 13 | 0.3% |
| Q1 2019 | 61 | $58.3M | 30,944,655 | 8 | 14 | 16 | 0.2% |
| Q4 2018 | 62 | $37.0M | 31,127,310 | 3 | 0 | 1 | 0.6% |